Who We Are
Attorneys for Securities, Antitrust, Consumer and Employment Law
Faruqi & Faruqi, LLP’s national practice focuses on complex civil litigation. The firm practices in the areas of Securities, Merger & Transactional, Shareholder Derivative, Antitrust, Consumer Class Action and Wage & Hour litigation.
Take Action
View our active case list and determine whether you want to participate in an action with us now
View All
Inform us of any fraud or unfair business practice using the link below
Report a Fraud
A class action suit can provide merger scrutiny to ensure you are protected
Merger Information
What we do
Investor & Shareholder Client Services
Faruqi & Faruqi strives to provide exceptional client services. These services include:
Portfolio Monitoring
We review the investment portfolios of institutional clients and prepare detailed reports.
Learn More
Corporate Governance and Regulatory Compliance
We monitor changes in the law to protect shareholders from corporate non-compliance.
Learn More
Case Evaluation
We perform complex damage analyses to evaluate the merit of clients’ cases.
Learn More
Legal Practice Areas
Civil Litigation Attorneys
Faruqi & Faruqi, LLP focuses on complex civil litigation, including securities, antitrust, wage and hour and consumer class actions as well as shareholder derivative and merger and transactional litigation. The firm is headquartered in New York, and maintains offices in California, Georgia, and Pennsylvania.
Are You an Affected Shareholder?
Faruqi & Faruqi, LLP is actively investigating the following cases:
17 Jul 2026
Regeneron Pharmaceuticals, Inc.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Regeneron To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Regeneron between August 1, 2025 and May 15, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Regeneron Pharmaceuticals, Inc. (““Regeneron” or the “Company”) (NASDAQ: REGN) and reminds investors of the September 14, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of Regeneron’s Phase III Fianlimab-Libtayo Study; notably, that its preliminary statistical assumptions were fundamentally flawed, that the active treatment arm was failing to achieve meaningful clinical differentiation over standard therapies, and that the trial would ultimately fail to reach statistical significance on its primary endpoint even without overperformance of the control arm.
Lead Plaintiff Deadline: September 14, 2026
Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
Or submit your information below to learn about your rights.
James M. Wilson, Jr.
Robert W. Killorin
Lead Plaintiff Deadline
59 Days
16 Jul 2026
Planet Fitness, Inc.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Planet Fitness To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Planet Fitness between November 6, 2025 and May 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Planet Fitness, Inc. (“Planet Fitness” or the “Company”) (NASDAQ: PLNT) and reminds investors of the [Deadline] deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose facts concerning the true state of Planet Fitness’ customer acquisition and marketing metrics. Notably, the Company’s updated marketing messaging was failing to resonate with, and was actively intimidating, its core target demographic of fitness beginners and casual gym-goers. As a result, Planet Fitness was experiencing a significant headwind in net member joins during its peak first-quarter sign-up period that rendered its previously issued fiscal 2026 guidance and long term financial targets unachievable.
Lead Plaintiff Deadline: September 14, 2026
Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
Or submit your information below to learn about your rights.
Robert W. Killorin
James M. Wilson, Jr.
Lead Plaintiff Deadline
59 Days
13 Jul 2026
Intuit Inc.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Intuit To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Intuit between August 22, 2025 and May 20, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Intuit Inc. (“Intuit” or the “Company”) (NASDAQ: INTU) and reminds investors of the September 8, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) they had overstated Intuit’s competitive advantages and growth, as well as the overall strength and sustainability of its business model and operations; (2) in reality, Intuit was losing significant business in its tax-related business, particularly in its Turbo Tax business, as a result of, inter alia, increasing competitive and pricing pressures; (3) accordingly, Intuit’s previously issued FY 2026 TurboTax revenue growth guidance was unreliable and/or unrealistic; and (4) as a result, Defendants’ public statements were materially false and misleading at all relevant times.
Lead Plaintiff Deadline: September 8, 2026
Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
Or submit your information below to learn about your rights.
James M. Wilson, Jr.
Robert W. Killorin
Lead Plaintiff Deadline
53 Days
8 Jul 2026
Photronics, Inc.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Photronics To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Photronics between December 10, 2025 and May 27, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Photronics, Inc. (“Photronics” or the “Company”) (NASDAQ: PLAB) and reminds investors of the September 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: The true state of Photronics’ high-end product pipeline, customer schedules, and the stability of the alleged demand for its products; notably, that the seasonal recovery and design release momentum following the Chinese New Year holiday the Company was claiming would develop had stalled. Photronics was experiencing a critical bottleneck in its design release pipeline that rendered its forward growth expectations unachievable.
Lead Plaintiff Deadline: September 4, 2026
Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
Or submit your information below to learn about your rights.
James M. Wilson, Jr.
Robert W. Killorin
Lead Plaintiff Deadline
49 Days
Our Attorneys
Meet Our Legal Team
Testimonials
Court Praises
The standing and ability of both petitioning counsel [Faruqi & Faruqi, LLP was one of the co-lead counsel]… is among the highest in our bar."
Vice Chancellor Sam Glasscock, III
Chancery Court of Delaware
I feel that counsel for plaintiffs evidenced that they were and are skilled in the field of securities litigation."
Judge Justin L. Quackenbush
United States District Court, District of Nevada
Although all of the firms seeking appointment as Lead Counsel have impressive resumes, the Court is most impressed with Faruqi & Faruqi."
Judge Timothy S. Black
United States District Court, Southern District of Ohio
There is no doubt that the law firms involved in this matter represented in my opinion the cream of the crop of class action business law and mergers and acquisitions litigators..."
Ira B. Warshawsky
Supreme Court of the State of New York, County of Nassau, Hon.
Plaintiffs Co-Lead Counsel have conducted the litigation and achieved the Settlement with skill, perseverance and diligent advocacy.”
Judge Freda L. Wolfson
United States District Court,
District of New Jersey
It is undisputed that counsel for the Plaintiffs are extremely competent and possess the necessary skills to represent Plaintiffs herein.”
Judge Michael D. Mason
Circuit Court for Montgomery County,
Maryland
Faruqi & Faruqi has extensive experience in the area of securities litigation and class actions. The firm’s resume indicates that it has litigated more than ten prominent securities class actions since its founding in 1995.”
Kimba M. Wood
United States District Court,
Southern District of New York